Osteoporosis, often called a silent disease, weakens bones and increases the risk of fractures, making it a leading cause of ...

Romosozumab plus alendronate vs alendronate alone was associated with improved lumbar spine BMD in postmenopausal women with T2D.

Treatment with romosozumab + alendronate vs alendronate alone led to improvements in tissue thickness-adjusted trabecular bone scores among postmenopausal women with osteoporosis. The study included ...